Funding · Company
Vinci Pharmaceuticals, Inc.
Avon By the Sea, NJHealthcare
Vinci Pharmaceuticals, Inc. of Avon By the Sea, NJ has disclosed $20M across 1 Form D offering filed with the SEC on Jan 26, 2026.
$20M
Total disclosed
1
Form D offering
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$20M
Form D · Jan 26, 2026 ↗
Q1 2026
· target $25M
Filing details
HeadquartersAvon By the Sea, NJIndustryHealthcare (Other Health Care)SEC CIK0001785495Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →